The global burden of NAFLD runs parallel to the prevalence of obesity  with the degree of hepatic triglyceride accumulation being proportional to the severity of each component of MetS4 With over two billion individuals with overweight/obesity expected worldwide by 2030  NAFLD is undoubtedly becoming the most prominent chronic liver disease of the 21st century in both adults and youths